Seeking Alpha
01 Oct 2026, 05:50 UTC · 58m ago
Verdict
Headline takes no side. We score LMAT +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 78% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
LeMaitre Vascular experienced a Q2 2026 earnings miss and issued lower guidance.
Priced inanalysis of Q2 results reported earlier
So whatThe resulting 27% price drop over the last 6 months suggests the market has already discounted the lowered FY2026 estimates.
More negative than 95% of claims this week
The FDA reported findings at the company's Artegraft plant.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inanalysis of Q2 results reported earlier
So whatDepending on the severity of the findings, potential remediation costs or shipment halts could hit Q3 or Q4 margins.
More negative than 90% of claims this week
LeMaitre's gross margin expanded from 65% to 72% due to a shift toward larger acquisitions.
Priced inanalysis of Q2 results reported earlier
So whatA 700bps margin expansion significantly increases the EPS contribution of each future accretive deal.
More positive than 79% of claims this week
The company holds $376M in cash and short-term investments.
Priced inanalysis of Q2 results reported earlier
So whatThis liquidity allows the company to fund several medium-sized acquisitions without needing dilutive equity raises in 2027.
More positive than 67% of claims this week
Which stocks this story touches
More positive than 78% of ticker scores this week
The analyst rates the stock as a 'Strong Buy' due to a robust M&A model and high margins, despite a recent earnings miss and FDA findings.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Invezz
2h ago
—
LMAT hasn't traded since this ran. Last close $82.59 (Sep 30); the reaction starts at the next open.
LMAT chart →
